How many insider declarations does 엑세스바이오 have?

엑세스바이오 has filed 1 insider declaration with DART (FSS).

Who is the top reporting insider at 엑세스바이오?

The top reporting insider at 엑세스바이오 is 엑세스바이오, based on the count of public filings.

What is the net insider buy vs sell volume on 엑세스바이오?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

엑

엑세스바이오: management transactions · South Korea · DART (FSS)

DART:company-7775afKR·DART (FSS)Mcap 133.7Bn€

AMF ↗

Browse the full insider trade history of 엑세스바이오, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Market capitalisation: €133.7bn. The latest transaction was filed on 12 March 2026 — Other. Among the most active insiders: 엑세스바이오. Every trade is openly available.

1

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

3280.00 €

Income statement

Revenue31.26 Bn€

Gross profit−24.45 Bn€-78% margin

Net income−82.12 Bn€-262.7% margin

Balance sheet & cash

Market cap133.66 Bn€

Total debt42.84 Bn€

Free Cash Flow−30.97 Bn€

Last declaration on 12 March 2026

All Executives1 Thresholds Prospectus Other

Declarations1 total

Executives●Other0DART

DART:20260312000891·12 Mar 2026details not loaded

DART ↗

1 of 1 declaration